Get started
Author

Roberta Pereira Trefiglio

Observed names: Roberta Trefiglio, Trefiglio, R.
ORCID: 0009-0007-1071-9034
Observed ORCID: 0009-0007-1071-9034
OpenAlex ID: A5063398736
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial
2007 · José Valdez Madruga, Pedro Cahn, et al. · The Lancet · 516
Recent HIV infection and annualized HIV incidence rates among sexual and gender minorities in Brazil and Peru (ImPrEP seroincidence study): a cross-sectional, multicenter study
2023 · Thiago S. Torres, Sylvia L.M. Teixeira, et al. · The Lancet Regional Health - Americas · 69
Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study
2024 · M Cristina Pimenta, Thiago Silva Torres, et al. · JMIR Public Health and Surveillance · 12
Exploring perceptions and preferences for PrEP choice and of an mHealth intervention: insights from the ImPrEP CAB‐Brasil study
2025 · Cristina Pimenta, Claudio G. Mann, et al. · Journal of the International AIDS Society · 10
PDF
Impact of regulatory assessment on clinical studies in Brazil
2016 · Luis Augusto Tavares Russo, Freddy Goldberg Eliaschewitz, et al. · Revista da Associação Médica Brasileira · 3
PDF
Person-centered choice and mHealth support for same-day delivery of long-acting injectable cabotegravir (ImPrEP CAB Brasil): a prospective, open-label, multicenter, quasi-experimental implementation study
2026 · Thiago Silva Torres, Brenda Hoagland, et al. · The Lancet Regional Health - Americas · 2
Preparing for implementation of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis within the Brazilian public health system: The ImPrEP CAB Brasil Study
2023 · Cristina Pimenta, Thiago Silva Torres, et al. · Research Square · 2
PDF
Integrating long-acting injectable cabotegravir for HIV prevention into the Brazilian public health system (ImPrEP CAB Brasil): a hybrid type-2 implementation-effectiveness cohort study
2026 · Beatriz Grinsztejn, Thiago Silva Torres, et al. · The Lancet HIV · 1
Description of the Serological Profile of Hepatitis a Among Individuals Seeking Hiv Pre-exposure Prophylaxis (prep) at a Reference Center in São Paulo
2026 · Mateus Ettori Cardoso, Ana Caroline Coutinho Iglessias, et al. · The Brazilian Journal of Infectious Diseases
Case Report: Hiv and the Diagnostic Challenge in a Patient With Vaccine-induced Seropositivity
2026 · Ana Caroline Coutinho Iglessias, Luciene Silva Arrifano, et al. · The Brazilian Journal of Infectious Diseases
Clinic and Provider Innovations to Improve Tuberculosis Infection Screening and Preventive Therapy Uptake in Brazil: Qualitative Findings From the PREVINE-TB Study
2026 · Deanna Kerrigan, Lelia H. Chaisson, et al. · Journal of the International Association of Providers of AIDS Care (JIAPAC)
Mapeamento de processos para apoiar a entrega de cabotegravir injetável de ação prolongada para profilaxia de pré-exposição ao HIV nos sistemas de saúde pública: o estudo IMPREP CAB BRASIL
2023 · Cohen, Mirian, O'Malley, G., et al. · Arca - Repositório Institucional da Fiocruz
Comparacao de tacrolimus com ciclosporina para imunossupressao apos transplante renal: revisao sistematica da literatura
2002 · Roberta Pereira Trefiglio · UNIFESP Institutional Repository (Universidade Federal de São Paulo)
Works count: 13
Citation count: 615
H-index: 4
I10-index: 4
Year
Topic
Type